ArticleCancers2021

Tris(dibenzylideneacetone)dipalladium(0) (Tris DBA) Abrogates Tumor Progression in Hepatocellular Carcinoma and Multiple Myeloma Preclinical Models by Regulating the STAT3 Signaling Pathway.

Loukik Arora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.